Fusidic Acid 2% + Beclomethasone 0.025% cream is a combination topical therapy used for the management of inflammatory skin conditions complicated by bacterial infection, offering both antibacterial and anti-inflammatory action.
Fusidic acid provides targeted antibacterial activity against Gram-positive bacteria, while beclomethasone dipropionate reduces inflammation, redness, and itching, ensuring faster relief from symptoms.
This cream is commonly prescribed for eczema, dermatitis, infected rashes, allergic skin reactions, and other inflammatory dermatoses, providing symptomatic relief and promoting skin healing.
With proven clinical efficacy, strong dermatological acceptance, and relevance in both acute and chronic skin care, this formulation enhances a dermatology-focused product portfolio and supports consistent therapeutic demand.